Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders" - Reply - Letter to the editor

被引:10
|
作者
Tollefson, GD [1 ]
Tran, PV [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Clin Res, Indianapolis, IN 46285 USA
关键词
D O I
10.1097/00004714-199804000-00016
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:177 / 179
页数:3
相关论文
共 50 条